The Enterprise Value as of September 2024 (TTM) for Fortress Biotech, Inc. (FBIOP) is 57.28M

According to Fortress Biotech, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 57.28M. This represents a change of 52.12% compared to the average of 37.65M of the last 4 quarters.

Fortress Biotech, Inc. (FBIOP) Historical Enterprise Value (quarterly & annually)

How has FBIOP Enterprise Value performed in the past?

The mean historical Enterprise Value of Fortress Biotech, Inc. over the last ten years is 52.13M. The current 57.28M Enterprise Value has changed 10.89% with respect to the historical average. Over the past ten years (40 quarters), FBIOP's Enterprise Value was at its highest in in the September 2020 quarter at 168.43M. The Enterprise Value was at its lowest in in the June 2022 quarter at -55255502.00.

Fortress Biotech, Inc. (FBIOP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Fortress Biotech, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Fortress Biotech, Inc. (FBIOP) Average Enterprise Value

How has FBIOP Enterprise Value performed in the past?

The current Enterprise Value of Fortress Biotech, Inc. (FBIOP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Fortress Biotech, Inc. (FBIOP) Enterprise Value vs. Peers

How is FBIOP’s Enterprise Value compared to its peers?

Fortress Biotech, Inc.’s Enterprise Value is less than Checkpoint Therapeutics, Inc. (0), less than Mustang Bio, Inc. (100.53M), greater than Reviva Pharmaceuticals Holdings, Inc. (6.34M), greater than Kodiak Sciences Inc. (33.31M), less than Fortress Biotech, Inc. (95.96M), less than Achilles Therapeutics plc (57.28M), greater than Aptose Biosciences Inc. (-61656377.00), greater than Indaptus Therapeutics, Inc. (-647435.00), greater than Rezolute, Inc. (8.12M), less than Tempest Therapeutics, Inc. (282.64M), greater than Comera Life Sciences Holdings, Inc. (23.29M), greater than Forte Biosciences, Inc. (-913895.00), greater than Cyteir Therapeutics, Inc. (1.13M), greater than XOMA Corporation (-20511738.00), less than Protagenic Therapeutics, Inc. (311.83M), greater than null (2.34M),

Build a custom stock screener for Fortress Biotech, Inc. (FBIOP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fortress Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fortress Biotech, Inc. (FBIOP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fortress Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.